Adverse respiratory effect of acute β -Blocker exposure in asthma: A systematic review and meta-analysis of randomized controlled trials

Chest

Volumn 145, Issue 4, 2014, Pages 779-786

  Morales, Daniel R ^a   Jackson, Cathy ^b   Lipworth, Brian J ^a   Donnan, Peter T ^a   Guthrie, Bruce ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BISOPROLOL; CELIPROLOL; LABETALOL; METOPROLOL; PLACEBO; PROPRANOLOL; STEROID;

ASTHMA; ATTRIBUTABLE RISK; BRONCHOCONSTRICTION; BRONCHOSPASM; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG EXPOSURE; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RECEPTOR BLOCKING; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ASTHMA; FORCED EXPIRATORY VOLUME; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84898757849     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1235     Document Type: Article

References (55)

1. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax. 2008;63(suppl 4):iv1-iv121.
2. Lipworth BJ, Williamson PA. Think the impossible: betablockers for treating asthma. Clin Sci (Lond). 2010; 118 (2): 115-120 .
3. Salpeter S, Ormiston T, Salpeter E. Cardioselective betablockers for reversible airway disease. Cochrane Database Syst Rev. 2002; (1): CD002992 .
4. Morales DR, Guthrie B, Lipworth BJ, Donnan PT, Jackson C. Prescribing of β-adrenoceptor antagonists in asthma: an observational study. Thorax. 2011; 66 (6): 502-507 .
5. Hanania NA, Singh S, El-Wali R, et al. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008; 21 (1): 134-141 .
6. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002; 31 (1): 140-149 .
7. Benson MK, Berrill WT, Cruickshank JM, Sterling GS. A comparison of four beta-adrenoceptor antagonists in patients with asthma. Br J Clin Pharmacol. 1978; 5 (5): 415-419 .
8. Beumer HM, Teirlinck C, Wiseman RA. Comparative investigation of the respiratory and cardiovascular effect of mepindolol, propranolol and pindolol in asthmatic patients. Int J Clin Pharmacol Biopharm. 1978; 16 (6): 249-253 .
9. Boye NP, Vale Jr. Effect in bronchial asthma of a new betaadrenergic blocking drug atenolol (ICI 66, 082). Eur J Clin Pharmacol. 1977; 11 (1): 11-14 .
10. Cannon RE, Slavin RG, Gonasun LM. The effect on asthma of a new beta blocker, pindolol. Am Heart J. 1982; 104(2 pt 2): 438-442 .
11. Chatterjee SS. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. J Cardiovasc Pharmacol. 1986; 8 (suppl 11): S74-S77 .
12. Chodosh S, Tuck J, Blasucci DJ. The effects of dilevalol, metoprolol, and placebo on ventilatory function in asthmatics. J Cardiovasc Pharmacol. 1988; 11 (suppl 2): S18-S24 .
13. Dal Negro RW, Tognella S, Micheletto C. Pharmacokinetics of the effect of Nebivolol 5mg on airway patency in patients with mild to moderate bronchial asthma and arterial hypertension. Clin Drug Investig. 2002; 22 (3): 197-204 .
14. Devereux G, Fishwick K, Aiken TC, Bourke SJ, Hendrick DJ. Adverse effects of a single dose of (1)-sotalol in patients with mild stable asthma. Br J Clin Pharmacol. 1998; 46 (1): 79-82 .
15. Doshan HD, Brown R, Applin WJ, Kapoor M, Caruso FS. Effects of high doses of celiprolol in asthmatic patients. J Cardiovasc Pharmacol. 1986; 8 (suppl 4): S109-S111 .
16. Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso FS. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. J Cardiovasc Pharmacol. 1986; 8 (suppl 4): S105-S108 .
17. Ellis ME, Sahay JN, Chatterjee SS, Cruickshank JM, Ellis SH. Cardioselectivity of atenolol in asthmatic patients. Eur J Clin Pharmacol. 1981; 21 (3): 173-176 .
18. Ellis ME, Hussain M, Webb AK, Barker NP, Fitzsimons TJ. The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients. Br J Clin Pharmacol. 1984; 17 (suppl 1): 59S-64S .
19. Falliers CJ, Vrchota J, Blasucci DJ, Maloy JW, Medakovic M. The effects of treatments with labetalol and hydrochlorothiazide on ventilatory function of asthmatic hypertensive patients with demonstrated bronchosensitivity to propranolol. J Clin Hypertens. 1985; 1 (1): 70-79 .
20. Falliers CJ, Vincent ME, Medakovic M. Effect of single doses of labetalol, metoprolol, and placebo on ventilatory function in patients with bronchial asthma: interaction with isoproterenol. J Asthma. 1986; 23 (5): 251-260 .
21. Fogari R, Zoppi A, Tettamanti F, Poletti L, Rizzardi G, Fiocchi G. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease. Cardiovasc Drugs Ther. 1990; 4 (4): 1145-1149 .
22. Jackson SH, Beevers DG. Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma. Br J Clin Pharmacol. 1983; 15 (5): 553-556 .
23. Lammers JW, Folgering HT, van Herwaarden CL. Ventilatory effects of atenolol and bevantolol in asthma. Clin Pharmacol Ther. 1985; 38 (4): 428-433 .
24. Larsson K. Influence of labetalol, propranolol and practolol in patients with asthma. Eur J Respir Dis. 1982; 63 (3): 221-230 .
25. Lawrence DS, Sahay JN, Chatterjee SS, Cruickshank JM. Asthma and beta-blockers. Eur J Clin Pharmacol. 1982; 22(6): 501-509 .
26. Löfdahl CG, Svedmyr N. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients. Eur J Respir Dis. 1981; 62 (6): 396-404 .
27. Löfdahl CG, Dahlöf C, Westergren G, Olofsson B, Svedmyr N. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline. Eur J Clin Pharmacol. 1988; 33 (suppl): S25-S32 .
28. Matthys H, Doshan HD, Rühle KH, et al. The bronchosparing effect of celiprolol, a new beta 1- alpha 2-receptor antagonist on pulmonary function of propranolol-sensitive asthmatics. J Clin Pharmacol. 1985 ; 25 (5): 354-359 .
29. Mue S, Sasaki T, Ohmi T, et al. Influence of Acebutolol on the haemodynamic and respiratory function of asthmatic patients. J Pharmacother. 1979 ; 2 (2): 67-71 .
30. Nair S, Maguire WC, Laddu AR. The effect of acebutolol, a beta adrenergic blocking agent, and placebo on pulmonary functions in asthmatics. Int J Clin Pharmacol Ther Toxicol. 1981; 19 (12): 519-526 .
31. Nicolaescu V, Manicatide M, Stroescu V. -Adrenergic blockade with practolol in acetylcholine-sensitive asthma patients. Respiration. 1972; 29 (2): 139-154 .
32. Nicolaescu V, Racoveanu C, Manicatide M. Effects of exercise on practolol-treated asthmatic patients. Eur J Clin Pharmacol. 1973; 6 (1): 3-8 .
33. Repsher LH, Vincent ME, Medakovic M. The effect of single doses of labetalol, metoprolol and placebo on ventilatory function in patients with bronchial asthma. J Hypertens. 1986; 4 (suppl 5) S510-S512 .
34. Skinner C, Gaddie J, Palmer KN. Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma. BMJ. 1975; 2 (5962): 59-61 .
35. Sue DY, Hansen JE, Wasserman K. The value of exercise in testing beta blockade and airway reactivity in asthmatic patients. Am Heart J. 1982; 104 (2 pt 2): 442-445 .
36. Suzuki S, Mue S, Ohmi T. Effect of atenolol on pulmonary function in asthma. Acta Ther. 1981; 7 (1): 55-65 .
37. Tantucci C, Bruni B, Dottorini ML, et al. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study. Am Heart J. 1990 ; 120 (2): 467-472 .
38. Thiringer G, Svedmyr N. Interaction of orally administered metoprolol, practolol and propranolol with isoprenaline in asthmatics. Eur J Clin Pharmacol. 1976; 10 (3-4): 163-170 .
39. Lawrence D.S, Sahay JN, Chatterjee SS, Cruickshank JM. β-Blockers in asthma. Drugs. 1983; 25 (suppl 2): 232-236 .
40. Matthys H, Doshan HD, Rühle KH, Applin WJ, Braig H, Pohl M. Bronchosparing properties of celiprolol, a new beta 1, alpha β-blocker, in propranolol-sensitive asthmatic patients. J Cardiovasc Pharmacol. 1986; 8 (suppl 4): S40-S42 .
41. Sue DY, Hansen JE, Wasserman K. Beta-adrenergic blockade with pindolol (LB-46) in mild to moderate asthma. Chest. 1981; 80 (5): 537-542 .
42. Short PM, Williamson PA, Lipworth BJ. Effects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction. Br J Clin Pharmacol. 2012; 73(5): 717- 726.
43. Hanania NA, Mannava B, Franklin AE, et al. Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J. 2010 ; 36 (4): 963-965 .
44. Short PM, Williamson PA, Anderson WJ, Lipworth BJ. Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma. Am J Respir Crit Care Med. 2013; 187 (12): 1308-1314 .
45. Basu K, Palmer CN, Tavendale R, Lipworth BJ, Mukhopadhyay S. Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. J Allergy Clin Immunol. 2009; 124(6): 1188-1194 .
46. Friren B, Michaud JE. Safety comparison of topical brinzolamide 1% and timolol 0.5% in patients with asthma or chronic obstructive pulmonary disease. Today's Therapeutic Trends. 2004; 22 (1): 69-80 .
47. Schoene RB, Abuan T, Ward RL, Beasley CH. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol. 1984; 97 (1): 86-92 .
48. Korte JM, Kaila T, Saari KM. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol. 2002; 240 (6): 430-435 .
49. Baker JG. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol. 2005; 144 (3): 317-322 .
50. Badgett RG, Lawrence VA, Cohn SL. Variations in pharmacology of beta-blockers may contribute to heterogeneous results in trials of perioperative beta-blockade. Anesthesiology. 2010; 113 (3): 585-592 .
51. Wheeldon NM, McDevitt DG, Lipworth BJ. Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects. Br J Clin Pharmacol. 1992; 34 (4): 337-343 .
52. Baudouin SV, Aitman TJ, Johnson AJ. Prazosin in the treatment of chronic asthma. Thorax. 1988; 43 (5): 385-387 .
53. Patel KR, Kerr JW. The airways response to phenylephrine after blockade of alpha and beta receptors in extrinsic bronchial asthma. Clin Allergy. 1973; 3 (4): 439-448 .
54. Dorow P. The role of alpha-receptors in bronchoconstriction induced by beta-blockade. Respiration. 1982; 43 (5): 359-362 .
55. Short PM, Williamson PA, Lipworth BJ. Sensitivity of impulse oscillometry and spirometry in beta-blocker induced bronchoconstriction and beta-agonist bronchodilatation in asthma. Ann Allergy Asthma Immunol. 2012; 109 (6): 412-415 .